kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Prime
CellSource Co., Ltd.
403
JPY
+7
(+1.77%)
Jan 29, 3:30 pm JST
2.63
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
397.9
Jan 29, 3:23 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.35
Yield
ー%
Margin Trading Ratio
27.13
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
394 JPY 2.57 USD
Previous Close Jan 28
396 JPY 2.59 USD
High Jan 29, 3:30 pm
403 JPY 2.63 USD
Low Jan 29, 9:01 am
391 JPY 2.55 USD
Volume
95,000
Trading Value
0.04B JPY 0.25M USD
VWAP
397.54 JPY 2.6 USD
Minimum Trading Value
40,300 JPY 263 USD
Market Cap
7.99B JPY 0.05B USD
Number of Trades
142
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
184
1-Year High May 28, 2025
954
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 222,300 532,300 2.39
Jan 16, 2026 208,600 531,900 2.55
Jan 9, 2026 190,900 563,400 2.95
Dec 26, 2025 151,800 547,100 3.60
Dec 19, 2025 183,700 538,500 2.93
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.